$5.52
8.45% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US29273B1044
Symbol
NDRA
Sector
Industry

ENDRA Life Sciences Inc. Stock price

$5.52
-4.28 43.67% 1M
-488.33 98.88% 6M
-3,704.48 99.85% YTD
-1,674.48 99.67% 1Y
-33,653.98 99.98% 3Y
-25,194.48 99.98% 5Y
-136,494.48 100.00% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.43 8.45%
ISIN
US29273B1044
Symbol
NDRA
Sector
Industry

Key metrics

Market capitalization $2.96m
Enterprise Value $-1.55m
P/E (TTM) P/E ratio 0.00
EV/FCF (TTM) EV/FCF 0.19
P/B ratio (TTM) P/B ratio 0.01
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-15.30m
Free Cash Flow (TTM) Free Cash Flow $-8.08m
Cash position $4.75m
EPS (TTM) EPS $-1,172.20
Short interest 4.64%
Show more

Is ENDRA Life Sciences Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

ENDRA Life Sciences Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast ENDRA Life Sciences Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast ENDRA Life Sciences Inc.:

Buy
100%

Financial data from ENDRA Life Sciences Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs 0.22 0.22
21% 21%
-
-0.22 -0.22
21% 21%
-
- Selling and Administrative Expenses 12 12
105% 105%
-
- Research and Development Expense 3.13 3.13
49% 49%
-
-15 -15
25% 25%
-
- Depreciation and Amortization 0.22 0.22
21% 21%
-
EBIT (Operating Income) EBIT -15 -15
24% 24%
-
Net Profit -8.82 -8.82
26% 26%
-

In millions USD.

Don't miss a Thing! We will send you all news about ENDRA Life Sciences Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ENDRA Life Sciences Inc. Stock News

Neutral
Business Wire
4 days ago
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it has regained compliance with the minimum bid price requirement set forth by The Nasdaq Stock Market LLC (“Nasdaq”). On November 21, 2024, the Company received notification from the Nasdaq Listing Qualifications Department confirming it...
Neutral
Business Wire
11 days ago
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months ended September 30, 2024 and provided a business update. Highlights from the third quarter and recent weeks include: Developed data analysis features for TAEUS platform by introducing new models root...
Neutral
Business Wire
20 days ago
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the European Patent Office has issued to ENDRA a new patent EP4247282 (the ‘282 patent) titled “Method and System for Monitoring Tissue Temperature.” The ‘282 patent relates to a novel method and system for monitoring tissue ablation during minima...
More ENDRA Life Sciences Inc. News

Company Profile

ENDRA Life Sciences, Inc. develops medical imaging technology. It operates Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

Head office United States
CEO Alexander Tokman
Employees 21
Founded 2007
Website www.endrainc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today